This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCL | MicrobiomeTrials
← Back to trials NCT04404283
Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCL Recruiting PHASE3 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2020-08-20Est. Completion: 2026-01-23
Enrollment target: 240 participantsLocations Central Alabama Research, Birmingham, Alabama, United States University of California Davis Comprehensive Cancer Center, Sacramento, California, United States University of California Davis Medical Center, Sacramento, California, United States Florida Cancer Specialists, Bonita Springs, Florida, United States Florida Cancer Specialists, Bradenton, Florida, United States Florida Cancer Specialists, Cape Coral, Florida, United States Florida Cancer Specialists, Daytona Beach, Florida, United States Florida Cancer Specialists, Fort Myers, Florida, United States Florida Cancer Specialists, Fort Myers, Florida, United States Florida Cancer Specialists, Naples, Florida, United States Florida Cancer Specialists, Port Charlotte, Florida, United States Florida Cancer Specialists, Sarasota, Florida, United States Florida Cancer Specialists, Sarasota, Florida, United States Florida Cancer Specialists, Stuart, Florida, United States Florida Cancer Specialists, Venice, Florida, United States Florida Cancer Specialists, Venice, Florida, United States Other microbiome trials you might be interested in Diffuse Large B-Cell Lymphoma, Not Otherwise Specified High Grade B-Cell Lymphoma Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma
This phase I trial studies the side effects and best dose of mosunetuzumab when given together with polatuzumab vedotin …
Duarte, United States Est. completion Jun 30, 2027
Ann Arbor Stage II Diffuse Large B-Cell Lymphoma Ann Arbor Stage III Diffuse Large B-Cell Lymphoma Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma
Florida Cancer Specialists, Vero Beach, Florida, United States
Florida Cancer Specialists, Wellington, Florida, United States
Florida Cancer Specialists, West Palm Beach, Florida, United States
MidAmerica Division, Inc. c/o Menorah Medical Center, Overland Park, Kansas, United States
University of Maryland, Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, United States
Karmanos Cancer Institute, Detroit, Michigan, United States
Henry Ford Hospital, Detroit, Michigan, United States
Karmanos Cancer Institute Weisberg Cancer Treatment Center, Farmington Hills, Michigan, United States
Henry Ford Medical Center - Columbus, Novi, Michigan, United States
Siteman Cancer Center - St. Peters, City of Saint Peters, Missouri, United States
Siteman Cancer Center - West County, Creve Coeur, Missouri, United States
MidAmerica Division, Inc. c/o Centerpoint Medical Center, Independence, Missouri, United States
MidAmerica Division, Inc., c/o Research Medical Center, Kansas City, Missouri, United States
Barnes Jewish-Hospital, St Louis, Missouri, United States
Washington University School of Medicine - Siteman Cancer Center, St Louis, Missouri, United States
Siteman Cancer Center - South County, St Louis, Missouri, United States
Siteman Cancer Center - North County, St Louis, Missouri, United States
Oncology_Hematology Care Clinical Trials,LLC, Cincinnati, Ohio, United States
University of Cincinnati Medical Center, Cincinnati, Ohio, United States
Oncology_Hematology Care Clinical Trials,LLC, Cincinnati, Ohio, United States
Oncology_Hematology Care Clinical Trials,LLC, Cincinnati, Ohio, United States
Oncology_Hematology Care Clinical Trials,LLC, Cincinnati, Ohio, United States
Oncology_Hematology Care Clinical Trials,LLC, Fairfield, Ohio, United States
West Chester Hospital, West Chester, Ohio, United States
Oncology Associates of Oregon, P.C., Eugene, Oregon, United States
Roper St. Francis Healthcare, Charleston, South Carolina, United States
Roper St. Francis Healthcare, Mt. Pleasant, South Carolina, United States
Roper St. Francis Healthcare, North Charleston, South Carolina, United States
US Oncology Investigational Products Center, Irving, Texas, United States
University of Virginia Cancer Center., Charlottesville, Virginia, United States
University of Virginia Health System, Charlottesville, Virginia, United States
Central Coast Local Health District, Gosford Hospital, Gosford, New South Wales, Australia
Central Coast Local Health District Wyong Hospital, Hamlyn Terrace, New South Wales, Australia
Royal Hobart Hospital, Hobart, Tasmania, Australia
Breakthrough Haematology Hollywood Specialist Centre, Nedlands, Western Australia, Australia
Hollywood Private Hospital, Nedlands, Western Australia, Australia
Royal Adelaide Hospital, Adelaide, Australia
Bellberry Limited, Eastwood, Australia
Tasmania Health and Medical HREC, Hobart, Australia
Hollywood Haematology, Nedlands, Australia
Ramsay National Research Unit and Research Governance Office, St Leonards, Australia
CHU UCL Namur-, Yvoir, Namur, Belgium
ZNA Middelheim, Antwerp, Belgium
ZNA Cadix, Antwerp, Belgium
Universitair Ziekenhuis Antwerpen, Edegem, Belgium
Universitair Ziekenhuis Gent, Ghent, Belgium
Chu Helora, Haine-Saint-Paul, Belgium
Eastern Regional Health Authority, St. John's, Newfoundland and Labrador, Canada
Queen Elizabeth II Health Science Centre, Halifax, Nova Scotia, Canada
London Health Sciences Centre, London, Ontario, Canada
The Ottawa Hospital - General Campus, Ottawa, Ontario, Canada
CISSS de la Monteregie-Centre, Greenfield Park, Quebec, Canada
Centre Integre Universitaire de la Santé et de Services Sociaux de l'Est-de-l'ile-de-Montreal,, Montreal, Quebec, Canada
Centre Integre Universitaire De Sante et de Services Sociaux Du Nord-de-I'ile-de-Montreal, Montreal, Quebec, Canada
Fakultni nemocnice Hradec Kralove, Hradec Králové, Czechia
Aalborg University Hospital, Aalborg, Denmark
Aarhus University Hospital, Aarhus N, Denmark
Clinical Trial Unit 2081, Copenhagen, Denmark
Zealand University Hospital Roskilde, Roskilde, Denmark
Centre de Lutte Contre le Cancer (CLCC) - Institut Bergonie, Bordeaux, Other, France
Centre Hospitalier(CH) de Perpignan, Perpignan, Other, France
Hôpital Lyon Sud, Pierre-Bénite, Other, France
CHU Angers - Hotel Dieu Nord, Service des Maladies du Sang, Angers, France
Centre Hospitalier Metropole Savoie, Chambéry, France
Centre Hospitalier Sud Francilien (CHSF), Corbeil-Essonnes, France
CHU Grenoble Alpes, Grenoble, France
Centre Hospitalier Le Mans, Le Mans, France
Service d'Hematologie Clinique, Limoges, France
Centre Hospitalier Regional Metz-Thionville Hopital Mercy Service d'hematologie, Metz, France
Centre Hospitalier Universitaire Nantes-Hotel Dieu, Service d'Hematologie, Nantes, France
Centre Antoine Lacassagne, Nice, France
Hopital Saint-Antoine -, Paris, France
Service d'Hematologie clinique et Therapie cellulaire CHU Bordeaux Hopital Haut-Leveque, Pessac, France
Centre Henri Becquerel, Rouen, France
CHRU Hopital de Tours, Tours, France
CHRU de Nancy - Hopitaux de Brabois, Service Hematologie et Medecine interne, Vandœuvre-lès-Nancy, France
Institut Gustave Roussy Département d'Innovations Thérapeutiques et d'Essais Précoces (DITEP), Villejuif, France
IRCCS Istituto Tumori Giovanni Paolo II U.O. Ematologia, Bari, Apulia, Italy
Azienda Ospedaliera "Cardinale Giovanni Panico", U.O.C. Ematologia e Trapianti Midollo Osseo, Tricase, Lecce, Italy
Istituto Europeo di Oncologia, Milan, MI, Italy
Azienda Ospedaliero-Universitaria di Bologna - IRCCS, Bologna, Other, Italy
Ospedale Maggiore ASUGI, Trieste, Italy
Pratia MCM Krakow, Krakow, Poland
Nasz Lekarz Osrodek Badan Klinicznych, Torun, Poland
National Cancer Center, Goyang-si, Gyeonggi-do, South Korea
The Catholic University of Korea, Suwon, Gyeonggi-do, South Korea
Jeonbuk National University Hospital, Jeonju, Jeollabuk-do, South Korea
Inje University Busan Paik Hospital, Busan, South Korea
Dong-A University Hospital., Busan, South Korea
Pusan National University Hospital, Busan, South Korea
Keimyung University Dongsan Hospital, Daegu, South Korea
Gachon University Gil Medical Center, Incheon, South Korea
Severance Hospital Yonsei University Health System, Seoul, South Korea
SoonChunHyang University Hospital Seoul, Seoul, South Korea
Asan Medical Center, Seoul, South Korea
Samsung Medical Center, Seoul, South Korea
The Catholic University of Korea, Seoul Saint Mary's Hospital, Seoul, South Korea
Institut Catala d'Oncologia - Hospital Duran i Reynals (ICO L'Hospitalet), L'Hospitalet de Llobregat, Catalonia, Spain
Hospital San Pedro de Alcantara, Cáceres, Extremadura, Spain
Hospital Universitario QuironSalud Madrid, Pozuelo de Alarcón, Madrid, Spain
Hospital Costa del Sol, Marbella, Malaga, Spain
Hospital de Navarra, Pamplona, Navarre, Spain
Hospital del Mar, Barcelona, Other, Spain
Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Hospital Universitari Vall d'Hebron, Barcelona, Spain
Hospital San Pedro de Alcantara, Cáceres, Spain
Hospital Universitario La Paz, Madrid, Spain
Hospital Universitario Fundacion Jimenez Diaz, Madrid, Spain
Hospital Universitario QuironSalud Madrid, Pozuelo de Alarcon (madrid), Spain
Hospital Clinico Universitario de Salamanca, Salamanca, Spain
Kantonsspital Winterthur, Medizinische Onkologie, Winterthur, Canton of Zurich, Switzerland
Universitatsspital Zurich, Zurich, Other, Switzerland
Universitatsspital Basel, Basel, Switzerland
National Taiwan University Hospital Clinical Trial Pharmacy, Taipei, R.o.c, Taiwan
National Taiwan University Hospital, Taipei, R.o.c, Taiwan
Chang Gung Medical Foundation, Kaohsiung City, Taiwan
National Cheng Kung University Hospital, Tainan, Taiwan
Chi Mei Hospital, Liouying, Tainan, Taiwan
Chi Mei Medical Center, Liouying, Tainan, Taiwan
Pharmacy Department, Taipei Veterans General Hospital, Taipei, Taiwan
Taipei Veterans General Hospital, Taipei, Taiwan
Chang Gung Medical Foundation, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan
University Hospitals Birmingham NHS Foundation Trust, Birmingham, WEST Midlands, United Kingdom
St Bartholomew's hospital, London, United Kingdom
Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom
The Royal Marsden NHS Foundation Trust, London, United Kingdom
The Royal Marsden NHS Foundation Trust, Sandwich, United Kingdom This randomized phase II trial studies how well rituximab and combination chemotherapy with or without lenalidomide work…
Anchorage, United States Est. completion Mar 26, 2020
Non-Hodgkin Lymphoma Diffuse Large B Cell Lymphoma (DLBCL)
This is a single center, single arm, open-label, dose escalation, phase 1 study to evaluate the safety, tolerability and…
Wuhan, China Est. completion Dec 31, 2028